Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2017-09-07 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
东兴证券股份有限公司关于公司终止资产重组事项之独立财务顾问专项核查意见
Capital/Financing Update Classification · 95% confidence The document is an independent financial advisor's special verification opinion regarding the termination of a major asset restructuring transaction by Guangzhou Yangpu Medical Technology Co., Ltd. It details the timeline of the asset purchase, the company's compliance with disclosure obligations during the stock suspension period, the reasons for termination, and the impact on the company. The document is not a full financial report but rather a verification opinion related to a specific corporate transaction and disclosure compliance. It does not contain financial statements or quarterly/yearly financial data. This type of document fits best under the category of Capital/Financing Update (CAP), as it relates to updates on a major asset purchase and restructuring activity, including its termination.
2017-09-07 Chinese
关于子公司与湖南郴州经济开发区管理委员会签署招商项目合作合同书的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Guangzhou Yangpu Medical Technology Co., Ltd. regarding the signing of a cooperation contract between its subsidiary and the Chenzhou Economic Development Zone Management Committee for an investment project. It details the contract terms, project location, rights and obligations of both parties, and the impact on the listed company. The document is a formal public announcement of a business cooperation agreement and investment project, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under Capital/Financing Update (CAP) as it relates to investment and capital deployment activities by the company.
2017-09-01 Chinese
关于投资建设阳普医疗健康产业园项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding its investment in constructing a medical health industrial park project. It details the project overview, investment scale, construction content, funding source, and potential risks. The document is a formal public announcement about a capital investment project, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but focuses on the company's capital expenditure plans and project approval by the board. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and contains substantive information about the investment, not just a brief notice or report publication announcement.
2017-08-30 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Guangzhou Yangpu Medical Technology Co., Ltd. It details the approval of an investment project by the board of directors, including voting results. The document references a related announcement published on the official disclosure website but does not contain full financial statements or detailed financial analysis. The content is about a board decision rather than a full report or financial filing. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on a board resolution, not a full report or announcement of a report publication.
2017-08-30 Chinese
关于资产收购事项的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the progress of an asset acquisition. It details the company's stock suspension and resumption related to a major asset restructuring, lists previous related announcements, and provides updates on due diligence and transaction methods. The document is relatively short (1729 characters) and focuses on ongoing progress and disclosure obligations rather than presenting full financial statements or detailed financial analysis. It is not a full annual or interim report, audit report, or earnings release. It is also not a proxy, voting result, or management change announcement. The content fits best as a Capital/Financing Update (CAP) because it concerns updates on a significant asset acquisition and related financing matters.
2017-08-28 Chinese
2017年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "广州阳普医疗科技股份有限公司 2017 年半年度报告全文" which translates to "Guangzhou Improve Medical Technology Co., Ltd. 2017 Semi-Annual Report Full Text." It contains detailed financial data, management discussion and analysis, company business overview, financial indicators, and other comprehensive information typical of an interim or quarterly report. The report covers the period from January 1, 2017 to June 30, 2017, which is a half-year period, consistent with an interim report. The document is lengthy (15,000 characters) and includes actual financial statements and substantive financial data, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-25 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.